MetaVia Inc. (NASDAQ:MTVA) Short Interest Up 177.8% in July

Posted by Latisha Jones on Jul 27th, 2026

MetaVia Inc. (NASDAQ:MTVA – Get Free Report) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 344,566 shares, a growth of 177.8% from the June 30th total of 124,038 shares. Based on an average daily volume of 1,041,508 shares, the short-interest ratio is presently 0.3 days. Currently, 6.7% of the company’s shares are sold short.

MetaVia Stock Performance

MTVA traded down $0.01 during mid-day trading on Monday, reaching $1.48. The stock had a trading volume of 82,523 shares, compared to its average volume of 1,848,320. The stock has a market capitalization of $7.61 million, a P/E ratio of -0.29 and a beta of 0.97. The firm’s fifty day simple moving average is $2.00 and its two-hundred day simple moving average is $2.08. MetaVia has a 52 week low of $0.97 and a 52 week high of $19.03.

MetaVia (NASDAQ:MTVA – Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of ($0.76) by ($0.03). As a group, analysts expect that MetaVia will post -2.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on MTVA shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of MetaVia in a report on Tuesday, July 21st. Wall Street Zen upgraded MetaVia to a “sell” rating in a research report on Saturday, June 20th. Finally, HC Wainwright restated a “buy” rating on shares of MetaVia in a report on Friday, July 10th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.00.

Get Our Latest Stock Analysis on MetaVia

Institutional Investors Weigh In On MetaVia

An institutional investor recently bought a new stake in MetaVia stock. Virtu Financial LLC acquired a new stake in shares of MetaVia Inc. (NASDAQ:MTVA – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 32,755 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned approximately 0.14% of MetaVia at the end of the most recent reporting period. 1.37% of the stock is currently owned by hedge funds and other institutional investors.

About MetaVia

(Get Free Report)

MetaVia Inc is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc, formerly known as NeuroBo Pharmaceuticals Inc, is based in CAMBRIDGE, Mass.